Intellectual Property Attorneys - IP Lawyers

Board of Patent Appeals: Species is not patentable when prior art discloses a genus encompassing the claimed species

Fu disclosed an imaging member for use in electrophotography containing a surfactant composed of a poly(fluoroacrylate)-graft-poly(methyl methacrylate). The USPTO rejected this application as obvious under 35 USC §103(a) in light of several patents, including a patent to Yamamoto, which disclosed a genus of surfactants having a perfluoroalkyl radical without specifically mentioning the compound disclosed by Fu, and a patent to Yoshida, which disclosed a fluorine-containing surfactant that was a poly(fluoroacry1ate)-graft-poly(methy1methacrylate).

 The Board of Patent Appeals affirmed the obviousness rejection. Applying KSR v. Teleflex, the court found that the prior art, specifically the Yamamoto and Yoshida patents, established a prima facie case of obviousness as to the Fu invention. Furthermore, the genus of surfactants disclosed by Yamamoto, while broad, contained a finite number of species and thus one having ordinary skill in the art would have "anticipated success" in trying the claimed surfactant species. Additionally, no secondary indicia of non-obviousness, such as teaching away from the invention by the prior art, were offered by the applicants.

In a precedential holding, the board stated: "We expressly reject the notion that a claim reciting a species is per se patentable when the prior art discloses a genus encompassing a broad but finite number of known options which include the claimed species. We hold that such aper se approach would be contrary to the clear command of our reviewing court. That is not to say, however, that an applicant would never be entitled to a patent in a situation as here. For example, KSR and Graham, as well as a myriad of precedents of our reviewing court, teach that secondary considerations such as unexpected results may confer particularly when that disclosure indicates a preference leading away from the claimed compounds."

Leave a comment

Pages

Disclaimer

This blog and the information contained in this blog are provided for general informational purposes only, are not intended to be legal advice, should not be construed as legal advice, and do not provide specific legal advice on any subject matter. No recipients of content from this blog, clients or otherwise, should act or refrain from acting on the basis of any content included in the blog without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the recipient’s state. This blog should not be used as a substitute for competent legal advice from a licensed professional attorney in your state or jurisdiction who is familiar with the specific facts of your situation. If you require legal advice, please consult with a competent attorney licensed to practice in your jurisdiction.